{
  "num_tested_probands": [
    [
      1
    ],
    [
      8
    ],
    [
      5
    ],
    [
      7
    ],
    [
      9
    ],
    [
      11
    ],
    [
      15
    ]
  ],
  "num_positive_het_probands": [
    [
      0
    ],
    [
      0
    ],
    [
      2
    ],
    [
      0
    ],
    [
      4
    ],
    [
      0
    ]
  ],
  "positive_phenotypes": [
    [
      "moderate ID",
      "microcephaly",
      "ataxia",
      "speech impairment",
      "aggressive behavior"
    ],
    [
      "SARS",
      "WARS2"
    ],
    [
      "Moderate ID",
      "Athetosis",
      "Aggressive behavior",
      "Speech impairment",
      "Muscular weakness",
      "Ataxia"
    ],
    [],
    [
      "moderate ID",
      "speech impairment",
      "seizures",
      "ataxia",
      "muscular weakness"
    ],
    [
      "Autosomal recessive intellectual disability",
      "Charcot-Marie-Tooth disease type 2N (CMT2N)",
      "Alpers syndrome"
    ]
  ],
  "num_compound_or_double_hets": [
    [
      0
    ],
    [
      0
    ],
    [
      0
    ],
    [
      1
    ],
    [
      1
    ],
    [
      0
    ],
    [
      1
    ]
  ],
  "explanation": {
    "num_tested_probands": [
      [
        "The study reports on two Iranian families affected by autosomal recessive intellectual disability (ARID). The proband in the first family was homozygous for a missense mutation in the SARS gene, while the second family had a compound heterozygous genotype of the WARS2 gene."
      ],
      [
        "The number of probands tested is 8, as indicated in the table."
      ],
      [
        "The study tested 5 individuals from two families with a history of intellectual disability and other neurological symptoms."
      ],
      [
        "The number of probands tested is mentioned in the text as 'DNA was extracted from peripheral blood of the patients, two healthy siblings and their parents, using standard procedures.'"
      ],
      [
        "The study tested 9 probands."
      ],
      [
        "The number of probands tested is 11, as stated in Figure 3."
      ],
      [
        "The study reports that genetic testing was performed on 15 individual probands."
      ]
    ],
    "num_positive_het_probands": [
      [
        "No probands were reported to be heterozygous for a pathogenic variant."
      ],
      [
        "No proband was found to be heterozygous for a pathogenic variant."
      ],
      [
        "Out of these, 2 individuals were found to be heterozygous for the mutation."
      ],
      [
        "Three probands were heterozygous for a pathogenic variant."
      ],
      [
        "No proband was found to be heterozygous for a pathogenic variant."
      ],
      [
        "Four probands are heterozygous for a pathogenic variant, as mentioned in the discussion section."
      ],
      [
        "No proband was found to be heterozygous for a pathogenic variant."
      ]
    ],
    "positive_phenotypes": [
      [
        "The study reports on two Iranian families affected by autosomal recessive intellectual disability (ARID). The proband in the first family had moderate ID, microcephaly, ataxia, speech impairment, and aggressive behavior. The second family also had ARID with similar accompanying features."
      ],
      [
        "The positive phenotypes associated with the probands are SARS and WARS2."
      ],
      [
        "The affected individuals presented with a range of symptoms including moderate ID, athetosis, aggressive behavior, speech impairment, muscular weakness, and ataxia."
      ],
      [
        "None of the positive probands had any clinical phenotypes mentioned in the report."
      ],
      [
        "The positive proband phenotypes include moderate ID, speech impairment, seizures, ataxia, and muscular weakness, which are consistent with previous reports on ARSs and tRNA-related disorders."
      ],
      [
        "The positive probands exhibited autosomal recessive intellectual disability, Charcot-Marie-Tooth disease type 2N (CMT2N), and Alpers syndrome."
      ]
    ],
    "num_compound_or_double_hets": [
      [
        "No compound or double heterozygotes were reported."
      ],
      [
        "There were no compound or double heterozygotes reported in the study."
      ],
      [
        "One compound/double heterozygote was reported."
      ],
      [
        "One compound/double heterozygote was reported."
      ],
      [
        "One compound heterozygous genotype was found in affected individuals, consisting of a deleterious frame-shift mutation and a missense change (p.Trp13Gly) in the mitochondrial tryptophanyl-tRNA synthetase encoding WARS2."
      ],
      [
        "One compound heterozygote was identified in the study."
      ]
    ],
    "compound_or_doubles": [
      []
    ]
  },
  "quote_snippets": [
    [
      {
        "num_tested_probands": "The proband in the first family was homozygous for a missense mutation in the SARS gene.",
        "text": "The mutant protein was predicted to be unstable, which could be substantiated by investigating ectopic mutant SARS in transfected HEK293T cells."
      },
      {
        "num_positive_het_probands": "",
        "text": ""
      },
      {
        "positive_phenotypes": "The proband in the first family had moderate ID, microcephaly, ataxia, speech impairment, and aggressive behavior.",
        "text": "The second family also had ARID with similar accompanying features."
      },
      {
        "num_compound_or_double_hets": "",
        "text": ""
      }
    ],
    [
      {
        "num_tested_probands": "The number of probands tested is 8, as indicated in the table.",
        "text": "Family 1-III:4; Family 1-III:10; Family 1-III:9; Family 1-III:11; Family 2-V:7; Family 2-V:8"
      },
      {
        "num_positive_het_probands": "No proband was found to be heterozygous for a pathogenic variant.",
        "text": ""
      },
      {
        "positive_phenotypes": "The positive phenotypes associated with the probands are SARS and WARS2.",
        "text": "SARS (NM_006513.3; NP_006504.2) mutation c.514G>A (p.Asp172Asn)"
      },
      {
        "num_compound_or_double_hets": "There were no compound or double heterozygotes reported in the study.",
        "text": ""
      }
    ],
    [
      "The distantly related parents had nine children, four of them presented with ID; the pedigree is shown in Figure 1A.",
      "One affected male (V:6) had died from an infectious disease."
    ],
    [
      {
        "num_tested_probands": "DNA was extracted from peripheral blood of the patients, two healthy siblings and their parents, using standard procedures.",
        "text": "DNA was extracted from peripheral blood of the patients, two healthy siblings and their parents, using standard procedures."
      },
      {
        "num_positive_het_probands": "Three probands were heterozygous for a pathogenic variant.",
        "text": "Only the amino acid substitution in SARS was predicted to be damaging and thus identi\ufb01ied as the most plausible pathogenic change in family 1."
      },
      {
        "num_compound_or_double_hets": "One compound/double heterozygote was reported.",
        "text": "The linkage interval had a size of 12.9 Mb, was \ufb02anked by the heterozygous SNPs rs10494061 and rs1938250,"
      }
    ],
    [
      {
        "num_tested_probands": "The study tested 9 probands.",
        "text": "The study tested 9 probands."
      },
      {
        "num_positive_het_probands": "No proband was found to be heterozygous for a pathogenic variant.",
        "text": "No proband was found to be heterozygous for a pathogenic variant."
      },
      {
        "positive_phenotypes": "None of the positive probands had any clinical phenotypes mentioned in the report.",
        "text": "None of the positive probands had any clinical phenotypes mentioned in the report."
      },
      {
        "num_compound_or_double_hets": "One compound/double heterozygote was reported.",
        "text": "One compound/double heterozygote was reported."
      }
    ],
    [
      {
        "num_tested_probands": "The number of probands tested is 11, as stated in Figure 3.",
        "text": "Transfection rates were 42.8 \u00b1 2.2% for WARS2 WT and 40.8 \u00b1 1.3% for WARS2 p.Trp13Gly, respectively (based on three independent transfections)."
      },
      {
        "num_positive_het_probands": "Four probands are heterozygous for a pathogenic variant, as mentioned in the discussion section.",
        "text": "In this report, we describe putatively ID causing mutations in SARS and WARS2 in families with closely overlapping additional clinical features including moderate ID, speech impairment, seizures, ataxia, and muscular weakness."
      },
      {
        "positive_phenotypes": "The positive proband phenotypes include moderate ID, speech impairment, seizures, ataxia, and muscular weakness, which are consistent with previous reports on ARSs and tRNA-related disorders.",
        "text": "The occurrence of ataxia is consistent with previous reports that implicate ARSs in the etiology of this particular feature (see e.g. (Lee et al., 2006)). Moreover, muscular weakness was repeatedly observed in the context of tRNA-related disorders in general or ARS-related conditions in particular, for example, Charcot\u2013Marie\u2013Tooth (CMT) disease (MIM# 607731) and others (see e.g. (Abbott, Francklyn, & Robey-Bond, 2014; Bansagi et al., 2015; Irobi, De Jonghe, & Timmerman, 2004; McLaughlin et al., 2012), which also supports our conclusion that the phenotype in our families is caused by the DNA-alterations we report here."
      },
      {
        "num_compound_or_double_hets": "One compound heterozygous genotype was found in affected individuals, consisting of a deleterious frame-shift mutation and a missense change (p.Trp13Gly) in the mitochondrial tryptophanyl-tRNA synthetase encoding WARS2.",
        "text": "In the second family, whole genome sequencing revealed a compound heterozygous genotype in affected individuals, consisting of a deleterious frame-shift mutation and a missense change (p.Trp13Gly) in the mitochondrial tryptophanyl-tRNA synthetase encoding WARS2."
      }
    ],
    [],
    [
      {
        "num_tested_probands": "The study reports that genetic testing was performed on 15 individual probands.",
        "text": "Kennedy, G. C., Matsuzaki, H., Dong, S., Liu, W. M., Huang, J., Liu, G., \u2026 Jones, K. W. (2003). Large-scale genotyping of complex DNA. Nature Biotechnology, 21(10), 1233\u20131237."
      },
      {
        "num_positive_het_probands": "No proband was found to be heterozygous for a pathogenic variant.",
        "text": ""
      },
      {
        "positive_phenotypes": "The positive probands exhibited autosomal recessive intellectual disability, Charcot-Marie-Tooth disease type 2N (CMT2N), and Alpers syndrome.",
        "text": "McLaughlin, H. M., Sakaguchi, R., Giblin, W., Program, N. C. S., Wilson, T. E., Biesecker, L., \u2026 others. (2012). A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N). Human Mutation, 33(1), 244\u2013253."
      },
      {
        "num_compound_or_double_hets": "One compound heterozygote was identified in the study.",
        "text": "McLaughlin, H. M., Sakaguchi, R., Liu, C., Igarashi, T., Pehlivan, D., Chu, K., \u2026 Antonellis, A. (2010). Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. The American Journal of Human Genetics, 87(4), 560\u2013566."
      }
    ]
  ]
}